共 50 条
- [1] A Multinational Report on Factors of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: Patient Selection and Follow-up INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E208 - E209
- [2] Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: Initial Clinical Experience INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E262 - E262
- [4] Is Renal Cell Carcinoma Really Radioresistant? Experience With Stereotactic Body Radiation Therapy in Patients for Primary and Metastatic Renal Cell Carcinoma AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 206 - 206
- [5] Stereotactic Body Radiation Therapy for Oligometastatic Renal Cell Carcinoma or Melanoma: Prognostic Factors and Outcomes INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E202 - E202
- [6] RENAL CELL CARCINOMA IS NOT RADIO-RESISTANT: THE SAFETY AND EFFICACY OF STEREOTACTIC BODY RADIATION THERAPY FOR PRIMARY LESION OF RENAL CELL CARCINOMA JOURNAL OF UROLOGY, 2019, 201 (04): : E917 - E917
- [7] The treatment of primary and metastatic renal cell carcinoma (RCC) with stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S316 - S316
- [9] Stereotactic body radiation therapy for primary renal cell carcinoma: A review on behalf of the CC-AFU FRENCH JOURNAL OF UROLOGY, 2024, 34 (7-8):